Perioperative management of a patient with Werlhof disease undergoing myocardial revascularization.
We herein report the case of a patient with idiopathic thrombocytopenic purpura (Werlhof disease) and coronary artery disease undergoing myocardial revascularization. The use of monomeric immunoglobulins, corticosteroids, platelets transfusion, use of a cell saver, normothermic cardiopulmonary bypass, aprotinine and homologous blood transfusion were combined in order to minimize the risk of bleeding complications in the postoperative period.
Gaudino
M
M
Department of Cardiac Surgery, Catholic University, Rome, Italy.
Luciani
N
N
Piancone
F L
FL
Bruno
P
P
Rossi
M
M
Schiavello
R
R
Possati
G
G
D000368:Aged; D002315:Cardiopulmonary Bypass; D003327:Coronary Disease / Q000150:complications* / Q000601:surgery*; D005260:Female; D006801:Humans; D009204:Myocardial Revascularization; D010976:Platelet Count; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D011184:Postoperative Period; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000150:complications*